Explore stories from Atlantic Canada.
Prices at the Pumps - May 8, 2024 #saltwire #pricesatthepumps #gaspricesBENGALURU - Indian drugmaker Abbott India reported a 24% rise in fourth-quarter profit on Thursday, as strong sales outpaced the impact of government pricing caps on certain medicines.
The company, which makes the popular antacid medicine Digene, said its profit rose to 2.87 billion rupees for the three months ended March 31, from 2.31 billion rupees a year earlier.Revenues of drugmakers such as Abbott India and GlaxoSmithKline Pharma India, which get most of their business from India, have been impacted after the inclusion of some of their drugs in the government's essential medicines list in September 2022, making them susceptible to price caps.
Abbott, which is a unit of U.S. healthcare firm Abbott Laboratories, has been trying to mitigate the impact of pricing curbs by driving up sales and cutting back on expenses. The company, which makes drugs including hypothyroidism treatment tablets Thyronorm, said its revenue from operations rose 7% to 14.39 billion rupees in the fourth quarter.It has been our privilege to have the trust and support of our East Coast communities for the last 200 years. Our SaltWire team is always watching out for the place we call home.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Drugmaker Abbott India posts Q4 profit rise on higher salesExplore stories from Atlantic Canada.
Read more »
Modi’s Central India Citadel Faces Religious Divide: India VotesEach day, Bloomberg journalists take you across a selection of towns and cities as they gear up for the big vote.
Read more »
Drugmaker Amneal agrees to $270 million U.S. opioid settlementExplore stories from Atlantic Canada.
Read more »
Drugmaker Amneal agrees to $270 million U.S. opioid settlementExplore stories from Atlantic Canada.
Read more »
CVC Explores Options for €11 Billion Drugmaker Recordati(Bloomberg) -- CVC Capital Partners is exploring options for its controlling stake in Italian drugmaker Recordati SpA, according to people familiar with the ...
Read more »
Africa’s Biggest Drugmaker Can Help Ease Obesity Medicine Supply CrunchAfrica’s biggest drugmaker could potentially help ease a growing supply crunch for the world’s hottest obesity medications.
Read more »